Catalyst Wire Dossier Catalyst Wire Dossier

LYNKUET

elinzanetant · Bayer HealthCare Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LYNKUET, covering 2025-10-24 to 2025-11-27. Get the full timeline:

Most recent: EMA Authorised: Lynkuet (elinzanetant) — Bayer AG

See pricing